US2005186639A1PendingUtilityA1
Gene originating in human chondrocyte
Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Jul 11, 1997Filed: Nov 29, 2004Published: Aug 25, 2005
Est. expiryJul 11, 2017(expired)· nominal 20-yr term from priority
C12N 5/0655C07K 14/4702C12N 2501/01C07K 14/47
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides a gene specifically expressed in differentiated human chrondrocytes. By culturing the chrondrocytes in the presence of dibutyryl cAMP, the chrondrocytes are cultured in a differentiated state and any gene is searched for which has a distinction in expression between differentiated chrondrocytes and dedifferentiated chrondrocytes. This allows the gene specifically expressed in the former to be obtained.
Claims
exact text as granted — not AI-modified1 - 7 . (canceled)
8 . A method of detecting a differentiated chondrocyte comprising:
contacting a chondrocyte with an anti-DEC1 antibody or antigen binding fragment thereof capable of specifically binding to a DEC-1 protein comprising the amino acid sequence of SEQ ID NO: 2.
9 . The method of claim 8 , wherein said antibody or antigen binding fragment thereof is selected from the group consisting of polyclonal antibodies, monoclonal antibodies and FAB fragments.
10 . The method of claim 8 , wherein said antibody or antigen binding fragment thereof is labeled.
11 . The method of claim 10 , wherein said label is selected from the group consisting of enzymes, isotopes and fluorescent substances.
12 . A method for modulating chondrogenesis, using an anti-DEC1 antibody capable of binding to the DEC1 protein comprising the amino acid sequence of SEQ ID NO: 2.
13 . A method for diagnosing abnormalities in chondrogenesis, using an anti-DEC1 antibody capable of binding to the DEC1 protein comprising the amino acid sequence of SEQ ID No: 2:Join the waitlist — get patent alerts
Track US2005186639A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.